84 related articles for article (PubMed ID: 25798539)
1. RNA-dependent protein kinase (PKR) depletes nutrients, inducing phosphorylation of AMP-activated kinase in lung cancer.
Guo C; Hao C; Shao R; Fang B; Correa AM; Hofstetter WL; Roth JA; Behrens C; Kalhor N; Wistuba II; Swisher SG; Pataer A
Oncotarget; 2015 May; 6(13):11114-24. PubMed ID: 25798539
[TBL] [Abstract][Full Text] [Related]
2. Integrin αvβ3 Upregulation in Response to Nutrient Stress Promotes Lung Cancer Cell Metabolic Plasticity.
Nam A; Jain S; Wu C; Campos A; Shepard RM; Yu Z; Reddy JP; Von Schalscha T; Weis SM; Onaitis M; Wettersten HI; Cheresh DA
Cancer Res; 2024 May; 84(10):1630-1642. PubMed ID: 38588407
[TBL] [Abstract][Full Text] [Related]
3. AMP-activated protein kinase (AMPK) suppresses Ibaraki virus propagation.
Ohkubo K; Shibutani S; Iwata H
Virology; 2024 Feb; 590():109943. PubMed ID: 38103268
[TBL] [Abstract][Full Text] [Related]
4. Preclinical evidence using synthetic compounds and natural products indicates that AMPK represents a potential pharmacological target for the therapy of pulmonary diseases.
Yang C; Rubin L; Yu X; Lazarovici P; Zheng W
Med Res Rev; 2024 May; 44(3):1326-1369. PubMed ID: 38229486
[TBL] [Abstract][Full Text] [Related]
5. AMPK is a mechano-metabolic sensor linking cell adhesion and mitochondrial dynamics to Myosin-dependent cell migration.
Crosas-Molist E; Graziani V; Maiques O; Pandya P; Monger J; Samain R; George SL; Malik S; Salise J; Morales V; Le Guennec A; Atkinson RA; Marti RM; Matias-Guiu X; Charras G; Conte MR; Elosegui-Artola A; Holt M; Sanz-Moreno V
Nat Commun; 2023 May; 14(1):2740. PubMed ID: 37217519
[TBL] [Abstract][Full Text] [Related]
6. XRN1 deletion induces PKR-dependent cell lethality in interferon-activated cancer cells.
Zou T; Zhou M; Gupta A; Zhuang P; Fishbein AR; Wei HY; Capcha-Rodriguez D; Zhang Z; Cherniack AD; Meyerson M
Cell Rep; 2024 Feb; 43(2):113783. PubMed ID: 38306275
[No Abstract] [Full Text] [Related]
7. Targeting AMPK for cancer prevention and treatment.
Li W; Saud SM; Young MR; Chen G; Hua B
Oncotarget; 2015 Apr; 6(10):7365-78. PubMed ID: 25812084
[TBL] [Abstract][Full Text] [Related]
8. Multiple myeloma acquires resistance to EGFR inhibitor via induction of pentose phosphate pathway.
Chen Y; Huang R; Ding J; Ji D; Song B; Yuan L; Chang H; Chen G
Sci Rep; 2015 Apr; 5():9925. PubMed ID: 25894462
[TBL] [Abstract][Full Text] [Related]
9. MLK3 phophorylates AMPK independently of LKB1.
Luo L; Jiang S; Huang D; Lu N; Luo Z
PLoS One; 2015; 10(4):e0123927. PubMed ID: 25874865
[TBL] [Abstract][Full Text] [Related]
10. Genetic Variants of the MDM2 Gene Are Predictive of Treatment-Related Toxicities and Overall Survival in Patients With Advanced NSCLC.
Qian J; Liu H; Gu S; Wu Q; Zhao X; Wu W; Wang H; Wang J; Chen H; Zhang W; Wei Q; Jin L; Lu D
Clin Lung Cancer; 2015 Sep; 16(5):e37-53. PubMed ID: 25818095
[TBL] [Abstract][Full Text] [Related]
11. LKB1/Mo25/STRAD uniquely impacts sarcomeric contractile function and posttranslational modification.
Behunin SM; Lopez-Pier MA; Birch CL; McKee LAK; Danilo C; Khalpey Z; Konhilas JP
Biophys J; 2015 Mar; 108(6):1484-1494. PubMed ID: 25809261
[TBL] [Abstract][Full Text] [Related]
12. AMPK-mediated energy homeostasis and associated metabolic effects on cancer cell response and resistance to cetuximab.
Li X; Lu Y; Lu H; Luo J; Hong Y; Fan Z
Oncotarget; 2015 May; 6(13):11507-18. PubMed ID: 25871473
[TBL] [Abstract][Full Text] [Related]
13. A critical role for PKR complexes with TRBP in Immunometabolic regulation and eIF2α phosphorylation in obesity.
Nakamura T; Kunz RC; Zhang C; Kimura T; Yuan CL; Baccaro B; Namiki Y; Gygi SP; Hotamisligil GS
Cell Rep; 2015 Apr; 11(2):295-307. PubMed ID: 25843719
[TBL] [Abstract][Full Text] [Related]
14. LKB1 and AMPKα1 are required in pancreatic alpha cells for the normal regulation of glucagon secretion and responses to hypoglycemia.
Sun G; da Silva Xavier G; Gorman T; Priest C; Solomou A; Hodson DJ; Foretz M; Viollet B; Herrera PL; Parker H; Reimann F; Gribble FM; Migrenne S; Magnan C; Marley A; Rutter GA
Mol Metab; 2015 Apr; 4(4):277-86. PubMed ID: 25830091
[TBL] [Abstract][Full Text] [Related]
15. Tumor progression and the different faces of the PERK kinase.
Pytel D; Majsterek I; Diehl JA
Oncogene; 2016 Mar; 35(10):1207-15. PubMed ID: 26028033
[TBL] [Abstract][Full Text] [Related]
16. Ski prevents TGF-β-induced EMT and cell invasion by repressing SMAD-dependent signaling in non-small cell lung cancer.
Yang H; Zhan L; Yang T; Wang L; Li C; Zhao J; Lei Z; Li X; Zhang HT
Oncol Rep; 2015 Jul; 34(1):87-94. PubMed ID: 25955797
[TBL] [Abstract][Full Text] [Related]
17. A simplified interventional mapping system (SIMS) for the selection of combinations of targeted treatments in non-small cell lung cancer.
Lazar V; Rubin E; Depil S; Pawitan Y; Martini JF; Gomez-Navarro J; Yver A; Kan Z; Dry JR; Kehren J; Validire P; Rodon J; Vielh P; Ducreux M; Galbraith S; Lehnert M; Onn A; Berger R; Pierotti MA; Porgador A; Pramesh CS; Ye DW; Carvalho AL; Batist G; Le Chevalier T; Morice P; Besse B; Vassal G; Mortlock A; Hansson J; Berindan-Neagoe I; Dann R; Haspel J; Irimie A; Laderman S; Nechushtan H; Al Omari AS; Haywood T; Bresson C; Soo KC; Osman I; Mata H; Lee JJ; Jhaveri K; Meurice G; Palmer G; Lacroix L; Koscielny S; Eterovic KA; Blay JY; Buller R; Eggermont A; Schilsky RL; Mendelsohn J; Soria JC; Rothenberg M; Scoazec JY; Hong WK; Kurzrock R
Oncotarget; 2015 Jun; 6(16):14139-52. PubMed ID: 25944621
[TBL] [Abstract][Full Text] [Related]
18. Reliability of Small Biopsy Samples Compared With Resected Specimens for the Determination of Programmed Death-Ligand 1 Expression in Non--Small-Cell Lung Cancer.
Kitazono S; Fujiwara Y; Tsuta K; Utsumi H; Kanda S; Horinouchi H; Nokihara H; Yamamoto N; Sasada S; Watanabe S; Asamura H; Tamura T; Ohe Y
Clin Lung Cancer; 2015 Sep; 16(5):385-90. PubMed ID: 25937270
[TBL] [Abstract][Full Text] [Related]
19. Symptom and Quality of Life Improvement in LUX-Lung 6: An Open-Label Phase III Study of Afatinib Versus Cisplatin/Gemcitabine in Asian Patients With EGFR Mutation-Positive Advanced Non-small-cell Lung Cancer.
Geater SL; Xu CR; Zhou C; Hu CP; Feng J; Lu S; Huang Y; Li W; Hou M; Shi JH; Lee KY; Palmer M; Shi Y; Lungershausen J; Wu YL
J Thorac Oncol; 2015 Jun; 10(6):883-9. PubMed ID: 25933111
[TBL] [Abstract][Full Text] [Related]
20. Metformin potentiates rapamycin and cisplatin in gastric cancer in mice.
Yu G; Fang W; Xia T; Chen Y; Gao Y; Jiao X; Huang S; Wang J; Li Z; Xie K
Oncotarget; 2015 May; 6(14):12748-62. PubMed ID: 25909163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
